Clinical trial
Treatment of Menstrual Cycle Alterations in Women With PCOS of Phenotype D Using Dietary Supplementation That Combines Diosgenin, Vitamin D and Alpha-lactalbumin
NCT06639698 is registered in ClinicalTrials.gov with Lo.Li.Pharma s.r.l as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Menstrual Cycle Alterations in Women With PCOS of Phenotype D Using Dietary Supplementation That Combines Diosgenin, Vitamin D and Alpha-lactalbumin
- Lead sponsor
- Lo.Li.Pharma s.r.l
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 14, 2024
- Completion date
- June 30, 2025
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pcos (polycystic ovary syndrome)